252 related articles for article (PubMed ID: 27251041)
1. Chromosomal Aberrations in Canine Gliomas Define Candidate Genes and Common Pathways in Dogs and Humans.
Dickinson PJ; York D; Higgins RJ; LeCouteur RA; Joshi N; Bannasch D
J Neuropathol Exp Neurol; 2016 Jul; 75(7):700-10. PubMed ID: 27251041
[TBL] [Abstract][Full Text] [Related]
2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
3. Molecular signalling pathways in canine gliomas.
Boudreau CE; York D; Higgins RJ; LeCouteur RA; Dickinson PJ
Vet Comp Oncol; 2017 Mar; 15(1):133-150. PubMed ID: 25808605
[TBL] [Abstract][Full Text] [Related]
4. [Histological and molecular classification of gliomas].
Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.
von Deimling A; Louis DN; von Ammon K; Petersen I; Wiestler OD; Seizinger BR
Cancer Res; 1992 Aug; 52(15):4277-9. PubMed ID: 1353411
[TBL] [Abstract][Full Text] [Related]
6. [Molecular cytogenetic analysis of chromosomal aberrations in cells of low grade gliomas and its contribution for tumour classification].
Lhotská H; Zemanová Z; Kramář F; Lizcová L; Svobodová K; Ransdorfová S; Bystřická D; Krejčík Z; Hrabal P; Dohnalová A; Kaiser M; Michalová K
Klin Onkol; 2014; 27(3):183-91. PubMed ID: 24918277
[TBL] [Abstract][Full Text] [Related]
7. Glioma biology and molecular markers.
Cohen AL; Colman H
Cancer Treat Res; 2015; 163():15-30. PubMed ID: 25468223
[TBL] [Abstract][Full Text] [Related]
8. Molecular classification of human gliomas using matrix-based comparative genomic hybridization.
Roerig P; Nessling M; Radlwimmer B; Joos S; Wrobel G; Schwaenen C; Reifenberger G; Lichter P
Int J Cancer; 2005 Oct; 117(1):95-103. PubMed ID: 15880582
[TBL] [Abstract][Full Text] [Related]
9. Genomic aberrations in diffuse low-grade gliomas.
Dahlback HS; Gorunova L; Brandal P; Scheie D; Helseth E; Meling TR; Heim S
Genes Chromosomes Cancer; 2011 Jun; 50(6):409-20. PubMed ID: 21412929
[TBL] [Abstract][Full Text] [Related]
10. [Towards a molecular classification of gliomas].
Hoang-Xuan K; Idbaih A; Mokhtari K; Sanson M
Bull Cancer; 2005 Apr; 92(4):310-6. PubMed ID: 15888387
[TBL] [Abstract][Full Text] [Related]
11. A network model of a cooperative genetic landscape in brain tumors.
Bredel M; Scholtens DM; Harsh GR; Bredel C; Chandler JP; Renfrow JJ; Yadav AK; Vogel H; Scheck AC; Tibshirani R; Sikic BI
JAMA; 2009 Jul; 302(3):261-75. PubMed ID: 19602686
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetics of gliomas.
Appin CL; Brat DJ
Cancer J; 2014; 20(1):66-72. PubMed ID: 24445767
[TBL] [Abstract][Full Text] [Related]
13. 'Putting our heads together': insights into genomic conservation between human and canine intracranial tumors.
Thomas R; Duke SE; Wang HJ; Breen TE; Higgins RJ; Linder KE; Ellis P; Langford CF; Dickinson PJ; Olby NJ; Breen M
J Neurooncol; 2009 Sep; 94(3):333-49. PubMed ID: 19333554
[TBL] [Abstract][Full Text] [Related]
14. Alterations in the RB1 pathway in low-grade diffuse gliomas lacking common genetic alterations.
Kim YH; Lachuer J; Mittelbronn M; Paulus W; Brokinkel B; Keyvani K; Sure U; Wrede K; Nobusawa S; Nakazato Y; Tanaka Y; Vital A; Mariani L; Ohgaki H
Brain Pathol; 2011 Nov; 21(6):645-51. PubMed ID: 21470325
[TBL] [Abstract][Full Text] [Related]
15. Interphase cytogenetics: a new tool for the study of genetic changes in brain tumors.
Arnoldus EP; Wolters LB; Voormolen JH; van Duinen SG; Raap AK; van der Ploeg M; Peters AC
J Neurosurg; 1992 Jun; 76(6):997-1003. PubMed ID: 1588436
[TBL] [Abstract][Full Text] [Related]
16. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype.
Smith JS; Alderete B; Minn Y; Borell TJ; Perry A; Mohapatra G; Hosek SM; Kimmel D; O'Fallon J; Yates A; Feuerstein BG; Burger PC; Scheithauer BW; Jenkins RB
Oncogene; 1999 Jul; 18(28):4144-52. PubMed ID: 10435596
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of chromosomal changes in human glioma progression. A cytogenetic study of 50 cases.
Debiec-Rychter M; Alwasiak J; Liberski PP; Nedoszytko B; Babińska M; Mrózek K; Imieliński B; Borowska-Lehman J; Limon J
Cancer Genet Cytogenet; 1995 Nov; 85(1):61-7. PubMed ID: 8536240
[TBL] [Abstract][Full Text] [Related]
18. Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss.
Ino Y; Zlatescu MC; Sasaki H; Macdonald DR; Stemmer-Rachamimov AO; Jhung S; Ramsay DA; von Deimling A; Louis DN; Cairncross JG
J Neurosurg; 2000 Jun; 92(6):983-90. PubMed ID: 10839259
[TBL] [Abstract][Full Text] [Related]
19. High-resolution genome-wide mapping of genetic alterations in human glial brain tumors.
Bredel M; Bredel C; Juric D; Harsh GR; Vogel H; Recht LD; Sikic BI
Cancer Res; 2005 May; 65(10):4088-96. PubMed ID: 15899798
[TBL] [Abstract][Full Text] [Related]
20. Identification of oligodendroglioma specific chromosomal copy number changes in the glioblastoma MI-4 cell line by array-CGH and FISH analyses.
Magnani I; Moroni RF; Roversi G; Beghini A; Pfundt R; Schoenmakers EF; Larizza L
Cancer Genet Cytogenet; 2005 Sep; 161(2):140-5. PubMed ID: 16102584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
